What is Anima?
Anima specializes in automated, always-on patient triage solutions designed to enhance the speed and efficiency of patient care. Founded in March 2021, the company addresses the critical issue of high workloads in primary care, which persists even with the adoption of telemedicine and e-consultations. Anima's technology aims to provide optimal patient care up to ten times faster than traditional teletriage or e-consultation methods, leveraging AI and automation to streamline clinical workflows.
How much funding has Anima raised?
Anima has raised a total of $14.5M across 2 funding rounds:
Angel/Seed
$2.5M
Series A
$12M
Angel/Seed (2021): $2.5M with participation from Amino Collective and Hummingbird Ventures
Series A (2024): $12M led by Draper Esprit, Y Combinator, and Hummingbird Ventures
Key Investors in Anima
Hummingbird Ventures
Hummingbird Ventures is a global seed investment fund that focuses on investing in outlier founders at the earliest stages of their ventures. They provide significant support throughout the lifecycle of the companies they back, investing amounts ranging from $500K at seed to over $50M as they scale. Emphasizing a partnership approach, Hummingbird values the perspectives of entrepreneurs and does not adhere to traditional investment models. Their philosophy centers on backing ambitious founders who are willing to challenge the status quo.
Draper Esprit
Draper Esprit, founded in 2006 and headquartered in London, UK, is a venture capital firm, with offices in London, Cambridge, and Dublin. Investing in high-growth technology companies with global ambitions.
Y Combinator
Established in 2005 and located in Mountain View, California, Y Combinator provides seed funding for startup businesses and to gauge investors for businesses.
What's next for Anima?
With its recent Series A financing, Anima is poised for accelerated growth and market penetration. The strategic investment suggests a strong validation of the company's technology and business model by its backers. Future developments will likely focus on expanding the platform's reach within the UK and potentially international markets, further refining its AI-driven triage capabilities, and forging new partnerships within the healthcare ecosystem. This capital infusion is expected to fuel product development, enhance sales and marketing efforts, and scale operational capacity to meet growing demand for efficient patient management solutions.
See full Anima company page
